Kaye Edward M. MD bought CYTK
October 16, 2026 · Form 4 insider transaction
Kaye Edward M. MD bought 195 shares of Cytokinetics, Incorporated at $63.92 per share, a transaction worth $12.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
195
Price
$63.92
Total value
$12.5K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 16, 2026
Filing dateOctober 20, 2026
Shares owned after10,629
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director equity in lieu of cash retainer program.